Executive News Wire

Fact-first intelligence synthesized across 12+ news agencies. Zero sensationalism.

Live Wire

CHRONOLOGICAL WIRE DISPATCHES

The NCRBuzz Standard

Every story is structurally partitioned: The News (pure facts), Key Takeaways, Historical Context, and Wire Attribution. Fact-first synthesis without sensationalism.

Aggregated from 12+ Wires Fact-Cross-Referenced

❤️ Support Bias-Free News

Help keep NCRBuzz 100% free of sensationalism, sponsored propaganda, and clickbait. Support our journalists via Google Reader Revenue.

Business & Stocks Livemint Markets & Economy • Oct 29, 2026

BLS Polymers Leads IPO GMP Comparison Against Bombay Coated & Paras Healthcare Amid Strong Market Demand

💡 Key Takeaways

•BLS Polymers leads the IPO GMP comparison with a 34% premium and 42.47x subscription by Day 3.
•Bombay Coated & Special Steels launched its Rs 183.06-crore IPO with an 11% GMP and Anand Rathi's recommendation.
•Paras Healthcare shares hit a record Rs 777, backed by a 'Buy' rating and Rs 900 target from Choice Institutional Equities.

NEW DELHI [NCRBuzz Wire] — **MUMBAI [NCRBuzz Wire] — BLS Polymers leads the current ipo gmp comparison among active primary market offerings, commanding a grey market premium equivalent to 34% of its issue price as it enters the final hours of its bidding window.** Evaluating urban company ipo gmp comparison trends alongside active listings highlights a dynamic divergence in investor sentiment across specialty manufacturing and healthcare segments.

### Financial Metrics & Market Performance

**Market participants are closely tracking subscription figures, valuation bands, and post-listing performance trajectories across major initial public offerings.** The following structured table provides a comparative overview of key financial and grey market metrics for the current offerings:

| :--- | :--- | :--- | :--- | :--- |

### Corporate Earnings & Valuation Outlook

**Bombay Coated & Special Steels opened its Rs 183.06-crore initial public offering entirely as a fresh issue of 2.23 crore shares, backed by steady FY26 financial expansion.** The firm posted a 20% growth in revenue and a 7% increase in profit for FY26, prompting Anand Rathi to issue a long-term subscription recommendation citing reasonable valuation metrics. Meanwhile, Paras Healthcare shares rebounded significantly, rising 5.4% to a record Rs 777 following an initial dip post-listing, supported by Choice Institutional Equities initiating coverage with a 'Buy' rating and a target price of Rs 900.

### Regulatory & Market Governance

**All primary market issuances strictly adhere to Securities and Exchange Board of India disclosure norms and merchant banking underwriting standards.** Investors are advised to evaluate individual risk appetites, financial statements, and subscription subscription ratios prior to deploying capital into ongoing book-building issues.

NCRBuzz Wire Desk ✓ Verified Wire

AI-synthesized and fact-audited across multiple independent news agencies.

Editorial Standards • About NCRBuzz

🏛️ Background Context

Indian primary capital markets have experienced robust retail and institutional participation, driven by consistent corporate earnings growth and favorable macroeconomic liquidity conditions under SEBI regulatory frameworks.

💡 Citizen & Commuter Quick Explainer (FAQ)

Q1: What is the current GMP of BLS Polymers IPO?

BLS Polymers carries a grey market premium (GMP) equivalent to 34% of its issue price, with subscription reaching 42.47 times by Day 3.

Q2: When does Bombay Coated & Special Steels IPO close?

The Rs 183.06-crore initial public offering of Bombay Coated & Special Steels remains open for subscription until November 2.

Q3: What is the target price for Paras Healthcare shares?

Choice Institutional Equities initiated coverage on Paras Healthcare with a 'Buy' rating and a target price of Rs 900.

Verified Wires: Livemint Markets & Economy, Economic Times Markets, Business Standard Original Wire Dispatch ↗

Link copied to clipboard

Executive News Wire

60-Sec Speed Wire

Article Headline

All Caught Up!